This is the authors' abstract. We don't add key points for this paper.
Several short-acting beta-adrenergic receptor blocking agents have been prepared by incorporating ester functions into the aryl portion of certain (aryloxy)propanolamine systems. In particular, methyl 3-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]propionate hydrochloride (ASL-8052) was found to be a moderately potent, cardioselective compound with a short duration of action when determined in in vivo canine models.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Erhardt et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: